Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Pseudoenhancement effects on iodine quantification from dual-energy spectral CT systems: A multi-vendor phantom study regarding renal lesion characterization.

Soesbe TC, Ananthakrishnan L, Lewis MA, Duan X, Nasr K, Xi Y, Abbara S, Leyendecker JR, Lenkinski RE.

Eur J Radiol. 2018 Aug;105:125-133. doi: 10.1016/j.ejrad.2018.06.002. Epub 2018 Jun 6.

PMID:
30017268
2.

Phantom Validation of Spectral Detector Computed Tomography-Derived Virtual Monoenergetic, Virtual Noncontrast, and Iodine Quantification Images.

Ananthakrishnan L, Duan X, Rajiah P, Soesbe TC, Lewis MA, Xi Y, Fielding JR, Lenkinski RE, Leyendecker JR, Abbara S.

J Comput Assist Tomogr. 2018 Jun 12. doi: 10.1097/RCT.0000000000000763. [Epub ahead of print]

PMID:
29901508
3.

Microstructural correlates of 3D steady-state inhomogeneous magnetization transfer (ihMT) in the human brain white matter assessed by myelin water imaging and diffusion tensor imaging.

Ercan E, Varma G, Mädler B, Dimitrov IE, Pinho MC, Xi Y, Wagner BC, Davenport EM, Maldjian JA, Alsop DC, Lenkinski RE, Vinogradov E.

Magn Reson Med. 2018 Apr 29. doi: 10.1002/mrm.27211. [Epub ahead of print]

PMID:
29707813
4.

Dual-layer spectral detector CT: non-inferiority assessment compared to dual-source dual-energy CT in discriminating uric acid from non-uric acid renal stones ex vivo.

Ananthakrishnan L, Duan X, Xi Y, Lewis MA, Pearle MS, Antonelli JA, Goerne H, Kolitz EM, Abbara S, Lenkinski RE, Fielding JR, Leyendecker JR.

Abdom Radiol (NY). 2018 Apr 7. doi: 10.1007/s00261-018-1589-x. [Epub ahead of print]

PMID:
29626256
5.

Whole-body MRI for metastatic cancer detection using T2 -weighted imaging with fat and fluid suppression.

Wang X, Pirasteh A, Brugarolas J, Rofsky NM, Lenkinski RE, Pedrosa I, Madhuranthakam AJ.

Magn Reson Med. 2018 Feb 14. doi: 10.1002/mrm.27117. [Epub ahead of print]

PMID:
29446127
6.

CEST-Dixon for human breast lesion characterization at 3 T: A preliminary study.

Zhang S, Seiler S, Wang X, Madhuranthakam AJ, Keupp J, Knippa EE, Lenkinski RE, Vinogradov E.

Magn Reson Med. 2018 Sep;80(3):895-903. doi: 10.1002/mrm.27079. Epub 2018 Jan 10.

PMID:
29322559
8.

Lactate Metabolism in Human Lung Tumors.

Faubert B, Li KY, Cai L, Hensley CT, Kim J, Zacharias LG, Yang C, Do QN, Doucette S, Burguete D, Li H, Huet G, Yuan Q, Wigal T, Butt Y, Ni M, Torrealba J, Oliver D, Lenkinski RE, Malloy CR, Wachsmann JW, Young JD, Kernstine K, DeBerardinis RJ.

Cell. 2017 Oct 5;171(2):358-371.e9. doi: 10.1016/j.cell.2017.09.019.

PMID:
28985563
9.

Z-spectrum appearance and interpretation in the presence of fat: Influence of acquisition parameters.

Zhang S, Keupp J, Wang X, Dimitrov I, Madhuranthakam AJ, Lenkinski RE, Vinogradov E.

Magn Reson Med. 2018 May;79(5):2731-2737. doi: 10.1002/mrm.26900. Epub 2017 Sep 1.

PMID:
28862349
10.

Addressing metabolic heterogeneity in clear cell renal cell carcinoma with quantitative Dixon MRI.

Zhang Y, Udayakumar D, Cai L, Hu Z, Kapur P, Kho EY, Pavía-Jiménez A, Fulkerson M, de Leon AD, Yuan Q, Dimitrov IE, Yokoo T, Ye J, Mitsche MA, Kim H, McDonald JG, Xi Y, Madhuranthakam AJ, Dwivedi DK, Lenkinski RE, Cadeddu JA, Margulis V, Brugarolas J, DeBerardinis RJ, Pedrosa I.

JCI Insight. 2017 Aug 3;2(15). pii: 94278. doi: 10.1172/jci.insight.94278. [Epub ahead of print]

11.

Image improvement method for positron emission mammography.

Slavine NV, Seiler SJ, McColl RW, Lenkinski RE.

Phys Med. 2017 Jul;39:164-173. doi: 10.1016/j.ejmp.2017.06.025. Epub 2017 Jul 5.

PMID:
28688583
12.

Quantification of Mouse Renal Perfusion Using Arterial Spin Labeled MRI at 1 T.

Do QN, Madhuranthakam AJ, Bendel P, Lenkinski RE.

Acad Radiol. 2017 Sep;24(9):1079-1085. doi: 10.1016/j.acra.2017.04.001. Epub 2017 May 8.

PMID:
28495212
13.

Spectral detector CT-derived virtual non-contrast images: comparison of attenuation values with unenhanced CT.

Ananthakrishnan L, Rajiah P, Ahn R, Rassouli N, Xi Y, Soesbe TC, Lewis MA, Lenkinski RE, Leyendecker JR, Abbara S.

Abdom Radiol (NY). 2017 Mar;42(3):702-709. doi: 10.1007/s00261-016-1036-9.

PMID:
28084546
14.

Balanced Steady-State Free Precession (bSSFP) from an effective field perspective: Application to the detection of chemical exchange (bSSFPX).

Zhang S, Liu Z, Grant A, Keupp J, Lenkinski RE, Vinogradov E.

J Magn Reson. 2017 Feb;275:55-67. doi: 10.1016/j.jmr.2016.12.002. Epub 2016 Dec 8.

15.

MR Neurography of Brachial Plexus at 3.0 T with Robust Fat and Blood Suppression.

Wang X, Harrison C, Mariappan YK, Gopalakrishnan K, Chhabra A, Lenkinski RE, Madhuranthakam AJ.

Radiology. 2017 May;283(2):538-546. doi: 10.1148/radiol.2016152842. Epub 2016 Dec 22.

PMID:
28005489
16.

Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.

Yuan Q, Costa DN, Sénégas J, Xi Y, Wiethoff AJ, Rofsky NM, Roehrborn C, Lenkinski RE, Pedrosa I.

J Magn Reson Imaging. 2017 Mar;45(3):908-916. doi: 10.1002/jmri.25391. Epub 2016 Jul 21.

PMID:
27442039
17.

Comparison of prostate cancer detection at 3-T MRI with and without an endorectal coil: A prospective, paired-patient study.

Costa DN, Yuan Q, Xi Y, Rofsky NM, Lenkinski RE, Lotan Y, Roehrborn CG, Francis F, Travalini D, Pedrosa I.

Urol Oncol. 2016 Jun;34(6):255.e7-255.e13. doi: 10.1016/j.urolonc.2016.02.009. Epub 2016 Mar 9.

PMID:
26971190
18.

Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin.

Vanderheiden A, Harrison LB, Warshauer JT, Adams-Huet B, Li X, Yuan Q, Hulsey K, Dimitrov I, Yokoo T, Jaster AW, Pinho DF, Pedrosa I, Lenkinski RE, Pop LM, Lingvay I.

J Clin Endocrinol Metab. 2016 Apr;101(4):1798-806. doi: 10.1210/jc.2015-3906. Epub 2016 Feb 24.

PMID:
26909799
19.

Metabolic Heterogeneity in Human Lung Tumors.

Hensley CT, Faubert B, Yuan Q, Lev-Cohain N, Jin E, Kim J, Jiang L, Ko B, Skelton R, Loudat L, Wodzak M, Klimko C, McMillan E, Butt Y, Ni M, Oliver D, Torrealba J, Malloy CR, Kernstine K, Lenkinski RE, DeBerardinis RJ.

Cell. 2016 Feb 11;164(4):681-94. doi: 10.1016/j.cell.2015.12.034. Epub 2016 Feb 4.

20.

Selective spectroscopic imaging of hyperpolarized pyruvate and its metabolites using a single-echo variable phase advance method in balanced SSFP.

Varma G, Wang X, Vinogradov E, Bhatt RS, Sukhatme VP, Seth P, Lenkinski RE, Alsop DC, Grant AK.

Magn Reson Med. 2016 Oct;76(4):1102-15. doi: 10.1002/mrm.26004. Epub 2015 Oct 28.

21.

pH imaging of mouse kidneys in vivo using a frequency-dependent paraCEST agent.

Wu Y, Zhang S, Soesbe TC, Yu J, Vinogradov E, Lenkinski RE, Sherry AD.

Magn Reson Med. 2016 Jun;75(6):2432-41. doi: 10.1002/mrm.25844. Epub 2015 Jul 14.

22.

An iterative deconvolution algorithm for image recovery in clinical CT: A phantom study.

Slavine NV, Guild J, McColl RW, Anderson JA, Oz OK, Lenkinski RE.

Phys Med. 2015 Dec;31(8):903-911. doi: 10.1016/j.ejmp.2015.06.009. Epub 2015 Jul 2.

PMID:
26143585
23.

UCEPR: Ultrafast localized CEST-spectroscopy with PRESS in phantoms and in vivo.

Liu Z, Dimitrov IE, Lenkinski RE, Hajibeigi A, Vinogradov E.

Magn Reson Med. 2016 May;75(5):1875-85. doi: 10.1002/mrm.25780. Epub 2015 May 29.

24.

Technical advancements in MR neurography.

Madhuranthakam AJ, Lenkinski RE.

Semin Musculoskelet Radiol. 2015 Apr;19(2):86-93. doi: 10.1055/s-0035-1547370. Epub 2015 Mar 12. Review.

PMID:
25764232
25.
26.

Prostatome: a combined anatomical and disease based MRI atlas of the prostate.

Rusu M, Bloch BN, Jaffe CC, Genega EM, Lenkinski RE, Rofsky NM, Feleppa E, Madabhushi A.

Med Phys. 2014 Jul;41(7):072301. doi: 10.1118/1.4881515.

27.

Novel PCA-VIP scheme for ranking MRI protocols and identifying computer-extracted MRI measurements associated with central gland and peripheral zone prostate tumors.

Ginsburg SB, Viswanath SE, Bloch BN, Rofsky NM, Genega EM, Lenkinski RE, Madabhushi A.

J Magn Reson Imaging. 2015 May;41(5):1383-93. doi: 10.1002/jmri.24676. Epub 2014 Jun 18.

PMID:
24943647
28.

Geometric distortion in diffusion-weighted MR imaging of the prostate-contributing factors and strategies for improvement.

Donato F Jr, Costa DN, Yuan Q, Rofsky NM, Lenkinski RE, Pedrosa I.

Acad Radiol. 2014 Jun;21(6):817-23. doi: 10.1016/j.acra.2014.02.001. Epub 2014 Apr 4.

29.

Statistical 3D Prostate Imaging Atlas Construction via Anatomically Constrained Registration.

Rusu M, Bloch BN, Jaffe CC, Rofsky NM, Genega EM, Feleppa E, Lenkinski RE, Madabhushi A.

Proc SPIE Int Soc Opt Eng. 2013 Mar 13;8669. doi: 10.1117/12.2006941.

30.

Hyperpolarized C-13 studies of cancer metabolism in animal models. Hype or real?

Lenkinski RE.

Eur J Radiol. 2012 Sep;81 Suppl 1:S85-6. doi: 10.1016/S0720-048X(12)70034-7. No abstract available.

PMID:
23083616
31.

Dedicated PET device for breast PET and MRI/PET correlations.

Seiler S, Lenkinski RE.

Eur J Radiol. 2012 Sep;81 Suppl 1:S149-50. doi: 10.1016/S0720-048X(12)70062-1. No abstract available.

PMID:
23083569
32.

CEST: from basic principles to applications, challenges and opportunities.

Vinogradov E, Sherry AD, Lenkinski RE.

J Magn Reson. 2013 Apr;229:155-72. doi: 10.1016/j.jmr.2012.11.024. Epub 2012 Dec 6.

33.

Embolization therapy for benign prostatic hyperplasia: influence of embolization particle size on gland perfusion.

Brook OR, Faintuch S, Brook A, Goldberg SN, Rofsky NM, Lenkinski RE.

J Magn Reson Imaging. 2013 Aug;38(2):380-7. doi: 10.1002/jmri.23981. Epub 2012 Dec 12.

PMID:
23239260
34.

Science to practice: Can hyperpolarized water be used to enhance MR angiography and flow measurement?

Lenkinski RE.

Radiology. 2012 Nov;265(2):325-6. doi: 10.1148/radiol.12121642.

PMID:
23093704
35.

In vitro MR imaging of renal stones with an ultra-short echo time magnetic resonance imaging sequence.

Yassin A, Pedrosa I, Kearney M, Genega E, Rofsky NM, Lenkinski RE.

Acad Radiol. 2012 Dec;19(12):1566-72. doi: 10.1016/j.acra.2012.07.008. Epub 2012 Sep 5.

PMID:
22959582
36.

Metabolic profile of PML lesions in patients with and without IRIS: an observational study.

Gheuens S, Ngo L, Wang X, Alsop DC, Lenkinski RE, Koralnik IJ.

Neurology. 2012 Sep 4;79(10):1041-8. doi: 10.1212/WNL.0b013e318268465b. Epub 2012 Aug 22.

37.

On shimming approaches in 3T breast MRI.

Hancu I, Govenkar A, Lenkinski RE, Lee SK.

Magn Reson Med. 2013 Mar 1;69(3):862-7. doi: 10.1002/mrm.24307. Epub 2012 May 3.

38.

Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.

Gheuens S, Smith DR, Wang X, Alsop DC, Lenkinski RE, Koralnik IJ.

Neurology. 2012 May 1;78(18):1390-3. doi: 10.1212/WNL.0b013e318253d61e. Epub 2012 Apr 18.

39.

Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.

Viswanath SE, Bloch NB, Chappelow JC, Toth R, Rofsky NM, Genega EM, Lenkinski RE, Madabhushi A.

J Magn Reson Imaging. 2012 Jul;36(1):213-24. doi: 10.1002/jmri.23618. Epub 2012 Feb 15.

40.

Keyhole chemical exchange saturation transfer.

Varma G, Lenkinski RE, Vinogradov E.

Magn Reson Med. 2012 Oct;68(4):1228-33. doi: 10.1002/mrm.23310. Epub 2012 Jan 13.

41.

pCEST: Positive contrast using Chemical Exchange Saturation Transfer.

Vinogradov E, Soesbe TC, Balschi JA, Sherry AD, Lenkinski RE.

J Magn Reson. 2012 Feb;215:64-73. doi: 10.1016/j.jmr.2011.12.011. Epub 2011 Dec 27.

42.

Clinical application of pharmacokinetic analysis as a biomarker of solitary pulmonary nodules: dynamic contrast-enhanced MR imaging.

Mamata H, Tokuda J, Gill RR, Padera RF, Lenkinski RE, Sugarbaker DJ, Butler JP, Hatabu H.

Magn Reson Med. 2012 Nov;68(5):1614-22. doi: 10.1002/mrm.24150. Epub 2012 Jan 9.

43.

Deuteration of a molecular probe for DNP hyperpolarization--a new approach and validation for choline chloride.

Allouche-Arnon H, Lerche MH, Karlsson M, Lenkinski RE, Katz-Brull R.

Contrast Media Mol Imaging. 2011 Nov-Dec;6(6):499-506. doi: 10.1002/cmmi.452.

PMID:
22144028
44.

Accurate prostate volume estimation using multifeature active shape models on T2-weighted MRI.

Toth R, Bloch BN, Genega EM, Rofsky NM, Lenkinski RE, Rosen MA, Kalyanpur A, Pungavkar S, Madabhushi A.

Acad Radiol. 2011 Jun;18(6):745-54. doi: 10.1016/j.acra.2011.01.016.

PMID:
21549962
45.

High-resolution computed tomography of single breast cancer microcalcifications in vivo.

Inoue K, Liu F, Hoppin J, Lunsford EP, Lackas C, Hesterman J, Lenkinski RE, Fujii H, Frangioni JV.

Mol Imaging. 2011 Aug;10(4):295-304. doi: 10.2310/7290.2010.00050. Epub 2011 Apr 1.

46.

Impact of nonrigid motion correction technique on pixel-wise pharmacokinetic analysis of free-breathing pulmonary dynamic contrast-enhanced MR imaging.

Tokuda J, Mamata H, Gill RR, Hata N, Kikinis R, Padera RF Jr, Lenkinski RE, Sugarbaker DJ, Hatabu H.

J Magn Reson Imaging. 2011 Apr;33(4):968-73. doi: 10.1002/jmri.22490.

47.

Perfusion imaging with a freely diffusible hyperpolarized contrast agent.

Grant AK, Vinogradov E, Wang X, Lenkinski RE, Alsop DC.

Magn Reson Med. 2011 Sep;66(3):746-55. doi: 10.1002/mrm.22860. Epub 2011 Mar 22.

48.

Determining histology-MRI slice correspondences for defining MRI-based disease signatures of prostate cancer.

Xiao G, Bloch BN, Chappelow J, Genega EM, Rofsky NM, Lenkinski RE, Tomaszewski J, Feldman MD, Rosen M, Madabhushi A.

Comput Med Imaging Graph. 2011 Oct-Dec;35(7-8):568-78. doi: 10.1016/j.compmedimag.2010.12.003. Epub 2011 Jan 21.

PMID:
21255974
49.

CEST and PARACEST MR contrast agents.

Hancu I, Dixon WT, Woods M, Vinogradov E, Sherry AD, Lenkinski RE.

Acta Radiol. 2010 Oct;51(8):910-23. doi: 10.3109/02841851.2010.502126. Review.

PMID:
20828299
50.

Clinical effects and brain metabolic correlates in non-invasive cortical neuromodulation for visceral pain.

Fregni F, Potvin K, Dasilva D, Wang X, Lenkinski RE, Freedman SD, Pascual-Leone A.

Eur J Pain. 2011 Jan;15(1):53-60. doi: 10.1016/j.ejpain.2010.08.002. Epub 2010 Sep 6.

Supplemental Content

Loading ...
Support Center